Navigation Links
Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape
Date:10/24/2011

Landscape, %, 2010 32

Figure 14: API Market, South and Central America, Revenues, $m, 2005-2016 35

Figure 15: API Market, South and Central America, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 37

Figure 16: API Market, South and Central America, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016 38

Figure 17: API Market, South and Central America, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 40

Figure 18: API Market, South and Central America, Revenue by Product Type Based on Customer Base, $m, 2005-2016 41

Figure 19: API Market, South and Central America, Revenue Share by Country, %, 2010 and 2016 43

Figure 20: API Market, The US, Revenues, $m, 2005-2016 46

Figure 21: API Market, The US, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 48

Figure 22: API Market, The US, Revenue by Product Type Based on Synthesis Route, $m, 2005-2016 49

Figure 23: API Market, The US, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 51

Figure 24: API Market, The US, Revenue by Product Type Based on Customer Base, $m, 2005-2016 52

Figure 25: API Market, The US, Revenue Share by Therapeutic Category, %, 2010 54

Figure 26: API Market, The US, SWOT, 2010 55

Figure 27: API Market, Canada, Revenues, $m, 2005-2016 58

Figure 28: API Market, Canada, Revenue Share by Product Type Based on Synthesis Route, %, 2010 and 2016 59

Figure 29: API Market, Canada, Revenue by Product Type Based on Synthesis Route, $m, 2010 and 2016 60

Figure 30: API Market, Canada, Revenue Share by Product Type Based on Customer Base, %, 2010 and 2016 62

Figure 31: API Market, Canada, Revenue by Product Type Based on Customer Base, $m, 2005-2016 63

Figure 32: API Market, Canada, Revenue Share by Therapeutic Category, %, 2010 65

Figure 33: API Market, Canada, SWOT, 2010 66
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
2. New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study
3. Semafores PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents
4. Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
5. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
6. New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials
7. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
8. Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
9. Results Published in the Journal Cancer Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
10. Going Beyond Spa Day: Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits
11. Radioactive Seed Therapy Shows Significant Reduction in Lung Cancer Recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)...  Acsis Inc., the market leader for supply ... recently posted an article, "Future of Running ... needs for companies, extended supply chain, and explains ... no longer work today.  The article explains how ... mobile technology, machine to machine (M2M) connectivity, and ...
(Date:7/25/2014)... According to a new market ... Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern and ... and Forecast (Value and Volume), 2013 - 2019", the ... in 2012 and is expected to grow at a ... USD 32.24 billion in 2019. Browse the ...
(Date:7/25/2014)... DUBLIN , July 25, 2014 ... the "Global Ophthalmic Diagnostic Devices Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 About Ophthalmic Diagnostic Device ... device used to identify a defect or deficiency in ... patients with ophthalmic disorders such as presbyopia, cataracts, glaucoma, ...
Breaking Medicine Technology:Acsis Addresses Questions on the Modern Supply Chain 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
... Simpson Eldredge Hersh & Jardine, P.C., one of the nations, ... lawsuit in Ohio against DePuy Orthopaedics, Inc. on behalf of ... ASR XL Acetabular System hip replacement. On August ... Johnson (NYSE: JNJ ), announced a voluntary recall ...
... Sept. 28 Cobalis Corp. (Pink Sheets: ... Call to provide investors and shareholders with further details and ... and legal issues. Shareholders and investors MUST RSVP ... October 5, 2010 at 1:15pm Pacific Time. Interested parties may ...
Cached Medicine Technology:Class Action Lawsuit Filed Against DePuy Orthopaedics, Inc. 2Cobalis Corp. Announces Second Update Conference Call for Investors on October 5, 2010 2
(Date:7/28/2014)... According to the Heartburn No More PDF review recently updated ... people get rid of acid reflux naturally. This ... and acid reflux. In addition, inside this book, people will ... for reflux disease. , Vkool informs in its review ... of reflux disease naturally without medications. The book also instructs ...
(Date:7/28/2014)... Shore Points Capital announced today that ... Loftware, Inc., through a recapitalization of the Company led ... lead investor in Loftware for over nine years, a ... international provider of enterprise level software solutions for supply ... investment for us, and we are proud of everything ...
(Date:7/27/2014)... 28, 2014 Hyaluronic Acid can hold ... the key to the power of Hyaluronic Serums. , ... Heshelow, founder of Sublime Beauty®. "But like collagen, it ... as ours improves skin moisture-retention and radiance." , ... to a healthy and beautiful look. Key Ingredients in ...
(Date:7/27/2014)... (HEV) transmission by blood components indicates that about 1 ... plasma. The findings, published in The Lancet , ... cells, platelets, and fresh frozen plasma) are likely to ... study retrospectively screened 225 000 individual blood donations collected ... 2013 for HEV RNA. 79 donors were found to ...
(Date:7/27/2014)... (PRWEB) July 27, 2014 The inaugural ... Latinos demonstrate their passion for protecting our environment and ... in the Southwest, will go on hiking or camping ... to show their support for permanently protecting our land, ... sharing the Latino community’s perspective on the environment like ...
Breaking Medicine News(10 mins):Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 3Health News:Shore Points Capital Announces Sale of Portfolio Company Loftware 2Health News:Aging or Dry Skin Benefits from Hyaluronic Serum; Now 30% Off Sale at Sublime Beauty® 2Health News:The Lancet: 1 in 3000 blood donors in England infected with hepatitis E 2Health News:Latino Conservation Action Week Launches, Highlights Latinos’ Dedication to Protecting Our Environment 2Health News:Latino Conservation Action Week Launches, Highlights Latinos’ Dedication to Protecting Our Environment 3
... MINRAD International, Inc. (Amex: BUF ) today ... NYSE Alternext US LLC (the "Exchange") stating that a ... September 30, 2008, indicated the Company was not in ... (the "Company Guide"), namely Section 1003(a)(i), with stockholders, equity ...
... now show their drugs don,t increase chances of cardiac ... U.S. Food and Drug Administration is now asking all ... medications to undertake studies that determine whether they cause ... comes on the heels of reports that two commonly ...
... concerns about costs and increased promiscuity among teenagers appear ... human papilloma virus (HPV) to prevent life-threatening diseases, according ... Public Health. , There is an ongoing public ... to prevent against genital warts and cervical cancer, but ...
... 17 Paramedics and emergency medical technicians (EMTs) employed ... and members of Teamsters Local 375 attended the company,s ... Employee shareholders expressed their frustration with the company,s ... a new contract in the greater Buffalo, New York ...
... Growing Jacksonville Market , , ... Company, Inc. (Nasdaq: IPCM ), a leading national ... North Florida Hospitalists (NFH) and Orange Park Hospitalists (OPH) of ... greater Jacksonville market, where the IPC has already established a ...
... /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), a life sciences ... services, today reported financial and operation results for the ... 2008. The Company announced a net loss of $3,568,321 ... October 31, 2008, and a net loss of $13,833,978 ...
Cached Medicine News:Health News:MINRAD Receives Notice of Failure to Satisfy a Continued Listing Rule from NYSE Alternext 2Health News:MINRAD Receives Notice of Failure to Satisfy a Continued Listing Rule from NYSE Alternext 3Health News:FDA Wants New Diabetes Drugs Tested for Heart Risks 2Health News:Fears of promiscuity pose barrier to cervical cancer vaccinations 2Health News:IPC The Hospitalist Company Acquires Two Florida Practices 2Health News:DiagnoCure announces fourth quarter 2008 and year-end results 2Health News:DiagnoCure announces fourth quarter 2008 and year-end results 3Health News:DiagnoCure announces fourth quarter 2008 and year-end results 4Health News:DiagnoCure announces fourth quarter 2008 and year-end results 5Health News:DiagnoCure announces fourth quarter 2008 and year-end results 6Health News:DiagnoCure announces fourth quarter 2008 and year-end results 7
... enable all those involved with healthcare decisions ... very latest evidence in their field of ... each year as the volume of evidence ... delivering the best single source available for ...
... concise yet complete eTextbook of standard ... disease. In addition to the Redi-Reference ... full desktop version is included at ... the electronic textbook, Redi-Reference provides periodic ...
ECG pocket is a handy reference for identifying common ECG findings....
... involved with healthcare decisions to keep up ... in their field of interest - a ... the volume of evidence increases. Cochrane Reviews ... single source available for continually updated evidence-based ...
Medicine Products: